UR-144 100g

Description

UR-144

UR-144 (TMCP-018, KM-X1, MN-001, YX-17) is a drug invented by Abbott Laboratories, that acts as a selective full agonist of the peripheral cannabinoid receptor CB2, but with much lower affinity for the psychoactive CB1 receptor.

UR-144

IUPAC name: (1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone

Formula: C21H29NO

Purity: 99,8% min

Appearance: white powder

The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic purposes.